Skip to main content
OpenTrials
Completed

NCT Number: NCT05428501

Awareness, Care & Treatment In Obesity Management - An Observation in Mainland China

ACTION China is a cross-sectional, observational, descriptive, and exploratory survey-based study without collection of laboratory data. The study is not related to any specific treatment options or pharmaceutical product. Collection of data will be performed via quantitative online survey by a third-party vendor.

The goal of this study is to provide insights to drive awareness around the needs of People Living with Obesity (PLwO) and Health Care Professionals (HCPs) involved in obesity treatment and management.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Obesity Body Weight Nutrition Disorders Nutritional and Metabolic Diseases Overnutrition Overweight Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Novo Nordisk Investigational Site

Beijing, China

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

PLwO:

  • Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
  • Male or female, aged above or equal to 18 years at the time of signing informed consent
  • Lives in mainland China and is native Chinese
  • Current BMI based on self-reported height and weight of at least 28 kg/m^2 as per mainland China definition of obesity(16) (calculated using an algorithm within the survey instrument)

HCPs:

  • Informed consent obtained before any study related activities (study-related activities are any procedure related to recording/collection of data according to the protocol)
  • Male or female, aged greather than or equal to18 years at the time of signing informed consent.
  • Physician with a license to practice
  • Specialty is not surgeon (including general, bariatric or plastic surgeon)
  • Practices in mainland China with at least 5 years in clinical practice
  • Spends at least 50% of time in direct patient care (as opposed to surgical procedures, office procedures or research/administrative tasks)
  • Has seen at least 100 patients in the past month
  • Has seen at least 10 patients needing weight management (defined as a patient with a BMI greather than or equal to28 kg/m^2 with or without comorbidities) in the past month

Exclusion criteria

PLwO

  • Previous participation in this study. Participation is defined as having given online consent in this study 2. Currently pregnant 3. Participates in intense fitness or body building programs 4. Has had significant, unintentional weight loss (due to major injury, illness, etc) in the past 6 months 5. Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation HCPs
  • Previous participation in this study. Participation is defined as having given informed consent in this study.
  • Unwillingness, inability, or language barriers precluding adequate understanding or cooperation

Treatment and study plan

No treatment given

Other

People / Person Living with Obesity (PLwO) Health Care Professionals (HCPs)

Primary outcomes

  1. Weight loss motivators

    Time frame: Day 1-day of survey

    Multi-selection from defined list

  2. PLwO / participants who made serious weight loss effort

    Time frame: Day 1-day of survey

    Percentage of participants

  3. Response to/evaluation of weight loss discussion according to predefined list of values

    Time frame: Day 1-day of survey

    Single selection from defined list

    • Not at all helpful
    • A little helpful
    • Somewhat helpful
    • Very helpful
    • Extremely helpful

  4. Effective weight loss methods

    Time frame: Day 1-day of survey

    Multi-selection from defined list

  5. Obesity attitudes

    Time frame: Day 1-day of survey

    5-point Likert scales:

    1: Do not agree at all 5: Completely agree

  6. Attitudes toward prescription weight loss medication and surgery

    Time frame: Day 1-day of survey

    5-point Likert scales:

    1: Do not agree at all 5: Completely agree

  7. Agreement with predefined Obesity and weight management measures

    Time frame: Day 1-day of survey

    5-point Likert scales:

    1: Do not agree at all 5: Completely agree

  8. Degree to which healthcare and society is meeting needs of PLwO

    Time frame: Day 1-day of survey

    5-point Likert scales:

    1: Not at all meeting the needs 5: Completely meeting the needs

Secondary outcomes

  1. Weight loss barriers

    Time frame: Day 1-day of survey

    Multi-selection from defined list

  2. Top factors for improving weight loss outcomes

    Time frame: Day 1-day of survey

    Multi-selection from defined list

  3. Types of weight management goals

    Time frame: Day 1-day of survey

    Multi-selection from defined list

  4. Most helpful information for participants for weight loss

    Time frame: Day 1-day of survey

    Multi-selection from defined list

  5. Responsibility for improving health of PLwO (rank of individuals/organizations in order of their responsibility)

    Time frame: Day 1-day of survey

    Rank of multi-selection from defined list of individuals/organizations in order of their responsibility.

    Ranks 1 - 3 where "1" means most responsible and "3" means least responsible

  6. Most helpful support for weight loss

    Time frame: Day 1-day of survey

    Multi-selection from defined list

  7. Effectiveness of guidelines for treating obesity

    Time frame: Day 1-day of survey

    5-point Likert scales:

    • Not at all effective
    • A little effective
    • Somewhat effective
    • Very effective
    • Extremely effective

  8. Ways participants receive information on weight loss management

    Time frame: Day 1-day of survey

    Multi-selection from defined list

Sponsors and collaborators

Lead sponsor

Novo Nordisk A/S

Industry

Registry information

Acronym: ACTION China

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Jun 23, 2022
Registry last updated
Sep 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.